Literature DB >> 29224809

Unplanned readmission following transoral robotic surgery.

Michael C Topf1, Amanda Vo2, Patrick Tassone3, Christopher Shumrick3, Adam Luginbuhl3, David M Cognetti3, Joseph M Curry3.   

Abstract

OBJECTIVES: To determine the rate of unplanned readmission after transoral robotic surgery (TORS), and to determine which patient or surgical factors increase the likelihood of readmission.
MATERIALS AND METHODS: Retrospective chart review of all patients who underwent TORS for squamous cell carcinoma at our institution from March 2010 through July 2016. Primary outcome was unplanned readmission to the hospital within 30 days of discharge. Univariable and multivariable logistic regression were performed to identify risk factors for unplanned readmission.
RESULTS: 297 patients met eligibility criteria. 23 patients (7.7%) had unplanned readmissions within 30 days. Most common reasons for readmission were oropharyngeal bleed (n = 13) and pain/dehydration (n = 10). Average time to unplanned readmission was 6.52 days (range 0-25 days). Discharge on clopidogrel was the only variable independently associated with an increased risk of 30-day unplanned readmission on multivariable analysis with an OR = 6.85 (95% CI 1.59-26.36). Unplanned return to the operating room during initial hospitalization (OR = 7.55, 95% CI 1.26-38.50) and discharge on clopidogrel (OR = 10.45, 95% CI 1.06-82.69) were associated with increased risk of postoperative bleeding. Bilateral neck dissection (OR = 5.17, 95% CI 1.15-23.08) was associated with significantly increased odds of unplanned readmission secondary to pain and dehydration.
CONCLUSION: Unplanned readmission following TORS occurs in a small but significant number of patients. Oropharyngeal bleeding and dehydration were the most common reasons for unplanned readmission following TORS.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bleeding; Dehydration; Oropharyngeal cancer; Transoral robotic surgery; Unplanned readmission

Mesh:

Substances:

Year:  2017        PMID: 29224809     DOI: 10.1016/j.oraloncology.2017.11.009

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  3 in total

1.  Evaluating the risks and benefits of ketorolac in transoral robotic surgery.

Authors:  Morgan M Sandelski; Sarah M Drejet; David Zimmer; Jessica A Yesensky; Michael Moore; Avinash V Mantravadi; Michael W Sim
Journal:  J Robot Surg       Date:  2021-01-16

2.  Association of comorbidity score with perioperative outcomes following transoral robotic surgery: National analysis.

Authors:  Neha Wadhavkar; Jeffrey B Jorgensen; Craig A Bollig
Journal:  Head Neck       Date:  2022-04-29       Impact factor: 3.821

Review 3.  Human Papillomavirus and Squamous Cell Carcinoma of Unknown Primary in the Head and Neck Region: A Comprehensive Review on Clinical Implications.

Authors:  Mikkel Hjordt Holm Larsen; Hani Ibrahim Channir; Christian von Buchwald
Journal:  Viruses       Date:  2021-07-02       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.